Overview of BioFIND
BioFIND is a two-year observational clinical study designed to discover and verify biomarkers of Parkinson's disease (PD). The study is carried out at multiple academic sites in the United States and began recruitment in 2012. BioFIND is collecting clinical data and biospecimens, including blood and cerebrospinal fluid (CSF), in a population of 120 well-defined, moderately advanced PD subjects and 120 healthy controls.
BioFIND will follow standardized data acquisition protocols to ensure that tests and assessments conducted at multiple sites can be pooled. Data and samples acquired from study participants will enable the development of a comprehensive Parkinson's database and biorepository, which will be available to the scientific community to conduct research on novel PD biomarkers. The study aims to complement the Parkinson’s Progression Markers Initiative (PPMI) to produce the most comprehensive and long-ranging dataset available for biomarker discovery work throughout the PD community.
Accessing Data and Biospecimens
While study recruitment is ongoing, clinical data and biospecimen from BioFIND are now available for request. Clinical data from BioFIND is hosted at the Laboratory of Neuro Imaging (LONI). Please visit the study site at LONI to apply for expedited access to available data and receive updates when additional data become available. To request access to available BioFIND samples, please complete and submit a letter of intent to theAccess Data and Biospecimens Program at The Michael J. Fox Foundation or email firstname.lastname@example.org for more information.
To view available biospecimens , click on the link below.
BioFIND Sample List